Diagnoses and Prevalence of HIV Infection Among Hispanics or Latinos — United States, 2008–2013
1; , DrPH1; , MS2; , MD, PhD1; , PhD1
, MPHHispanics or Latinos* represent about 17% of the total U.S. population and are disproportionately affected by human immunodeficiency virus (HIV) infection in the United States (1,2). In 2013, the rate of HIV diagnosis among Hispanics or Latinos (18.7) was nearly three times that of non-Hispanic whites (6.6) (1). To better characterize HIV infection among Hispanics or Latinos aged ≥13 years in the United States, CDC analyzed data from the National HIV Surveillance System (NHSS). During 2008–2013, the rate of diagnoses of HIV infection among adult and adolescent Hispanics or Latinos decreased from 28.3 per 100,000 population in 2008 to 24.3 in 2013 (estimated annual percentage change [EAPC] = -3.6); however, the number of diagnoses among males with infection attributed to male-to-male sexual contact increased 16%, from 6,141 in 2008 to 7,098 in 2013 (EAPC = 3.0). In 2013, the rate of diagnosis of HIV infection among males (41.3) was six times the rate among females (6.8). During 2008–2013, behavioral risk factors for HIV infection among Hispanics or Latino differed among males and females and by place of birth. Among Hispanic or Latino males born in Puerto Rico, the proportion of HIV infections attributed to injection drug use (24.9%) was greater than among those born elsewhere. Among HIV-infected Hispanic or Latino females, those born in the United States (21.2%) and Puerto Rico (20.5%) had a greater proportion of HIV infections attributed to injection drug use than those born elsewhere. Additional interventions and public health strategies to further decrease the rates of HIV among the Hispanic or Latino population are needed.
Data from NHSS reported to CDC from the early 1980s through December 2014 were used to determine the numbers and rates of diagnosis of HIV infection among Hispanics or Latinos aged ≥13 years (adults and adolescents) during 2008–2013 and prevalence in 2012, by selected characteristics. The numerator for each rate was the estimated number of diagnoses of HIV infection by diagnosis year. Appropriate subpopulations from the census or postcensus data from the U.S. Census Bureau were used for the denominator (2). Rates of infection by HIV transmission categories (male-to-male sexual contact, injection drug use, male-to-male sexual contact and injection drug use, heterosexual contact, or other) could not be calculated because the U.S. Census does not collect the data needed for the denominators. In calculating the EAPC in rates, populations were treated as actual populations and not samples, because the standard deviation of these populations was not available from the U.S. Census. Data from NHSS were also used to ascertain 1) HIV diagnoses in 2013 among Hispanics or Latinos by place of birth and transmission category, and 2) the numbers and rates of Hispanics or Latinos living with diagnosed HIV infection at year-end 2012 by area of residence at diagnosis. Birthplace information was available for 83.7% of Hispanics or Latinos in this analysis. Data were statistically adjusted for reporting delays and missing HIV transmission categories (3).
During 2008–2013, a total of 276,633 adults and adolescents received a diagnosis of HIV infection in the 50 states and the District of Columbia. Of these, 57,406 (20.8%) were Hispanics or Latinos. A decline was observed in the rates of diagnosis per 100,000 population among Hispanic or Latino adults and adolescents, from 28.3 per 100,000 population in 2008 to 24.3 in 2013 (EAPC = -3.6) (Table 1). During 2008–2013, the HIV diagnosis rate decreased among Hispanic or Latino males from 45.0 per 100,000 to 41.3 (EAPC = -2.0) and among females from 10.1 per 100,000 to 6.8 (EAPC = -9.6). The rates remained stable or decreased among all age groups, with the largest decline among persons aged 35–44 years (39.6 per 100,000 to 29.5 [EAPC = -6.8]). Among Hispanic or Latino males with infection attributed to male-to-male sexual contact, the number of HIV diagnoses increased 16% (EAPC = 3.0), whereas diagnoses decreased in other transmission categories (Figure). Among Hispanic or Latino females, the estimated number of HIV diagnoses decreased in persons with infection attributed to injection drug use or heterosexual contact. The largest declines in males (EAPC = -8.6) and females (EAPC = -11.8) were observed among those with infection attributed to injection drug use (Table 1).
In 2013, the HIV diagnosis rate per 100,000 population among males (41.3) was more than six times the rate among females (6.8). By age group, the highest rate of HIV diagnosis (40.1) among Hispanics or Latinos occurred among persons aged 25–34 years. By transmission category, the largest number of HIV diagnoses occurred among males with infection attributed to male-to-male sexual contact (7,098 [82.8%]), and among females with infection attributed to heterosexual contact (1,194 [87.2%]) (Table 1). The estimated rate of diagnosis for 2013 ranged from 2.3 in Idaho to 90.1 in the District of Columbia (Table 2).
HIV transmission category among Hispanics or Latinos varied by place of birth (Table 3). Infection attributed to male-to-male sexual contact accounted for the majority of infection transmissions among males, irrespective of place of birth, ranging from a low of 53.6% among persons born in Puerto Rico to a high of 86.4% among persons born in South America. Hispanic or Latino males born in Puerto Rico had a higher proportion of HIV infections attributed to injection drug use (24.9%) than those born elsewhere, whereas Hispanic or Latino females born in the United States (21.2%) and Puerto Rico (20.5%) had a higher proportion of HIV infections attributed to injection drug use than those born elsewhere. A smaller proportion of Hispanic or Latino males born in the United States (6.6%) had infection attributed to heterosexual contact compared with male Hispanics or Latinos born elsewhere. A smaller proportion of Hispanic or Latino females born in the United States (78.2%) and Puerto Rico (79.2%) had infection attributed to heterosexual contact compared with female Hispanics or Latinos born elsewhere.
At year-end 2012, an estimated 911,602 adults and adolescents were living with diagnosed HIV infection, and of these, 183,300 (20.1%) were Hispanics or Latinos (Table 2); the rate of persons living with HIV infection among Hispanics or Latinos was estimated at 458.8 per 100,000 population, and the estimated HIV prevalence ranged from 73.6 per 100,000 population in Montana to 1,947.5 in the District of Columbia (Table 2).
Discussion
During 2008–2013, overall diagnoses of HIV infection among adult and adolescent Hispanics or Latinos decreased in the United States. However, decreases have not occurred uniformly because diagnoses of HIV infection among men who have sex with men increased. This increase might have resulted from increased incidence of HIV infection, an increase in HIV testing among Hispanic or Latino men who have sex with men, or a combination of both of these factors (4).
An estimated 43% of Hispanics or Latinos who received an HIV diagnosis were not born in the United States or Puerto Rico (a U.S. territory), and among these Hispanic or Latino immigrants, 66% were men who have sex with men. The large proportion of HIV diagnoses in the United States among Hispanics or Latinos who are immigrants is important to consider when developing HIV prevention interventions, given that approximately 40% of Hispanic or Latino immigrants do not speak English well or at all (5) and because certain socioeconomic factors, such as limited access to health care, lack of health insurance, and poverty, might be at play (6).
Findings from this report also confirm earlier findings that Hispanics or Latinos are not a homogenous group, and risk factors differ by place of birth (7,8). The majority of males born in Puerto Rico with infection diagnosed during 2008–2013 had infections attributed to male-to-male sexual contact, highlighting a change in HIV transmission patterns, which until recently indicated that the most common HIV transmission category among men in Puerto Rico was injection drug use (9). Still, a much larger proportion of Hispanic or Latino males born in Puerto Rico reported infection attributed to injection drug use compared with Hispanic or Latino males born elsewhere. HIV care providers working in communities where Puerto Ricans reside should be mindful of a recent report indicating that levels of linkage to care, retention in care, prescription of antiretroviral therapy, and viral suppression were lower among Hispanics or Latinos with HIV infection attributed to injection drug use than among those with infection attributed to male-to-male sexual contact and heterosexual contact (10).
The findings in this report are subject to at least two limitations. First, misclassification of Hispanics or Latinos as members of other races/ethnicities might have resulted in underestimation of the number of Hispanics or Latinos overall and of Hispanic or Latino subgroups. Second, birthplace information was missing for 16% of Hispanics or Latinos in this analysis. Depending on the distribution of birthplaces for persons with missing information, transmission category prevalence for certain subgroups might have been larger or smaller.
The disproportionate rate of HIV infection among Hispanics or Latinos and the disparities found within this population indicate that much work still needs to be done to reach Hispanics or Latinos at high risk for acquiring or transmitting HIV infection. CDC and its partners are pursuing a high-impact prevention approach to maximize the effectiveness of current HIV prevention methods. Example activities include providing technical assistance to health departments and community-based organizations to deliver effective prevention interventions to Hispanics or Latinos, and supporting testing projects and campaigns that focus on Hispanics or Latinos, such as Reasons, which encourages HIV testing among Hispanic or Latino men who have sex with men. CDC funds health departments across the United States and its territories for core HIV prevention activities, including activities for Hispanics or Latinos, and supports projects to optimize care outcomes, such as the Care and Prevention in the United States demonstration project, which promotes increased testing and linkage to, retention in, and reengagement in care for racial and ethnic minorities living with HIV (6).
1Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC; 2ICF International, Atlanta, Georgia.
Corresponding author: Kristen Mahle Gray, kgray1@cdc.gov, 404-639-2050.
References
- CDC. Diagnoses of HIV infection in the United States and dependent areas, 2013. HIV Surveillance Report 2015(25). Available at http://www.cdc.gov/hiv/library/reports/surveillance/2013/surveillance_report_vol_25.html.
- US Census Bureau. Population estimates. Available at http://www.census.gov/popest/data.
- Harrison KM, Kajese T, Hall HI, Song R. Risk factor redistribution of the national HIV/AIDS surveillance data: an alternative approach. Public Health Rep 2008;123:618–27.
- Johnson AS, Hall HI, Hu X, Lansky A, Holtgrave DR, Mermin J. Trends in diagnoses of HIV infection in the United States, 2002–2011. JAMA 2014;312:432–4.
- US Census Bureau. American Community Survey, 2012. English-speaking ability of the foreign-born population in the United States. Available at https://www.census.gov/content/dam/Census/library/publications/2014/acs/acs-26.pdf.
- CDC. HIV among Latinos. Available at http://www.cdc.gov/hiv/group/racialethnic/hispaniclatinos/index.html.
- CDC. HIV/AIDS among Hispanics—United States, 2001–2005. MMWR Morb Mortal Wkly Rep 2007;56:1052–7.
- Espinoza L, Hall HI, Hu X. Diagnoses of HIV infection among Hispanics/Latinos in 40 states and Puerto Rico, 2006–2009. J Acquir Immune Defic Syndr 2012;60:205–13.
- CDC. Incidence and diagnoses of HIV infection—Puerto Rico, 2006. MMWR Morb Mortal Wkly Rep 2009;58:589–91.
- CDC. Hispanics or Latinos living with diagnosed HIV: progress along the continuum of HIV care—United States, 2010. MMWR Morb Mortal Wkly Rep 2014;63:886–90.
* Hispanics or Latinos can be of any race.
Summary
What is already known on this topic?
Hispanics or Latinos represent about 17% of the total U.S. population and are disproportionately affected by human immunodeficiency virus (HIV) infection in the United States. In 2013, the rate of HIV diagnosis among Hispanics or Latinos (18.7 per 100,000) was nearly three times that of non-Hispanic whites (6.6).
What is added by this report?
During 2008–2013, the overall rate of the diagnoses of HIV infection among adult and adolescent Hispanics or Latinos decreased (from 28.3 per 100,000 in 2008 to 24.3 in 2013; estimated annual percentage change [EAPC] = -3.6); however, diagnoses of HIV infection among males with infection attributed to male-to-male sexual contact increased (EAPC = 3.0).
What are the implications for public health practice?
The higher rate of HIV infection among Hispanics or Latinos indicates that much work still needs to be done to reach Hispanics or Latinos at high risk for acquiring or transmitting HIV infection. Targeted strategies for Hispanic or Latino subpopulations, such as men who have sex with men and persons who inject drugs, present prevention challenges and warrant expanded efforts.
FIGURE. Estimated number of diagnoses attributed to male-to-male sexual contact* compared with other transmission categories among Hispanic or Latino males aged ≥13 years, by year — United States, 2008–2013
* Male-to-male sexual contact does not include male-to-male sexual contact and injection drug use combined.
Alternate Text: The figure above is a line chart showing the estimated number of diagnoses attributed to male-to-male sexual contact compared with other transmission categories among Hispanic or Latino males aged ≥13 years, by year, in the United States during 2008-2013.
TABLE 3. (Continued) Diagnoses of HIV infection* among adult and adolescent Hispanics or Latinos, by transmission category and place of birth — United States, 2008–2013 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Characteristic |
United States |
Other† |
Unknown¶ |
Total |
||||||||
No. |
Est. no.§ |
% |
No. |
Est. no.§ |
% |
No. |
Est. no.§ |
% |
No. |
Est. no.§¶ |
% |
|
Transmission category |
||||||||||||
Male adult and adolescent |
||||||||||||
Male-to-male sexual contact |
14,623 |
17,345 |
81.6 |
748 |
977 |
70.8 |
4,473 |
6,709 |
83.5 |
30,985 |
38,923 |
80.1 |
Injection drug use |
905 |
1,404 |
6.6 |
28 |
95 |
6.9 |
220 |
541 |
6.7 |
1,904 |
3,154 |
6.5 |
Male-to-male sexual contact and injection drug use |
887 |
1,089 |
5.1 |
37 |
48 |
3.5 |
157 |
260 |
3.2 |
1,522 |
1,987 |
4.1 |
Heterosexual contact** |
1,189 |
1,402 |
6.6 |
167 |
258 |
18.7 |
376 |
520 |
6.5 |
3,401 |
4,506 |
9.3 |
Other†† |
2,668 |
26 |
0.1 |
341 |
2 |
0.2 |
2,352 |
5 |
0.1 |
8,550 |
52 |
0.1 |
Subtotal |
20,272 |
21,266 |
100.0 |
1,321 |
1,380 |
100.0 |
7,578 |
8,035 |
100.0 |
46,362 |
48,620 |
100.0 |
Female adult or adolescent |
||||||||||||
Injection drug use |
497 |
795 |
21.2 |
11 |
40 |
6.2 |
58 |
194 |
14.6 |
726 |
1,305 |
14.8 |
Heterosexual contact** |
1,850 |
2,938 |
78.2 |
314 |
598 |
93.6 |
461 |
1,137 |
85.2 |
4,257 |
7,442 |
84.7 |
Other†† |
1,253 |
23 |
0.6 |
282 |
1 |
0.1 |
737 |
3 |
0.3 |
3,394 |
39 |
0.4 |
Subtotal |
3,600 |
3,757 |
100.0 |
607 |
639 |
100.0 |
1,256 |
1,334 |
100.0 |
8,377 |
8,786 |
100.0 |
Total§§ |
23,872 |
25,022 |
100.0 |
1,928 |
2,019 |
100.0 |
8,834 |
9,369 |
100.0 |
54,739 |
57,406 |
100.0 |
Abbreviations: Est. = estimated; HIV = human immunodeficiency virus. * Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis. † Places of birth other than those specified. § Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing risk-factor information but not for incomplete reporting. ¶ Entries include persons whose place of birth is not among those listed and persons whose place of birth is unknown. ** Heterosexual contact with a person known to have, or to be at high risk for, HIV infection. †† Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified. §§ Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column might not sum to the column total. |
Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of
Health and Human Services.
References to non-CDC sites on the Internet are
provided as a service to MMWR readers and do not constitute or imply
endorsement of these organizations or their programs by CDC or the U.S.
Department of Health and Human Services. CDC is not responsible for the content
of pages found at these sites. URL addresses listed in MMWR were current as of
the date of publication.
All MMWR HTML versions of articles are electronic conversions from typeset documents.
This conversion might result in character translation or format errors in the HTML version.
Users are referred to the electronic PDF version (http://www.cdc.gov/mmwr)
and/or the original MMWR paper copy for printable versions of official text, figures, and tables.
An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S.
Government Printing Office (GPO), Washington, DC 20402-9371;
telephone: (202) 512-1800. Contact GPO for current prices.
**Questions or messages regarding errors in formatting should be addressed to
mmwrq@cdc.gov.